MASSACHUSETTS FINANCIAL SERVICES CO /MA/MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Institutional investor · Portfolio as of Q1 2019

Top Holdings832 positions

Checking export access…
Activity:

Accenture PLC

32.9M$5.8B2.4%$159.240.00%
1 qtr
First report
0

Comcast Corp

140.7M$5.6B2.4%$29.810.00%
1 qtr
First report
0

Medtronic PLC

56.9M$5.2B2.2%$73.570.00%
1 qtr
First report
0

Thermo Fisher Scientific Inc

17.8M$4.9B2.1%$268.250.00%
1 qtr
First report
0

Visa Inc

29.3M$4.6B1.9%$148.120.00%
1 qtr
First report
0

Johnson & Johnson

28.2M$3.9B1.7%$113.770.00%
1 qtr
First report
0

Microsoft Corp

32.9M$3.9B1.6%$110.120.00%
1 qtr
First report
0

AON PLC

22.6M$3.9B1.6%$161.380.00%
1 qtr
First report
0

Honeywell International Inc

24.2M$3.8B1.6%$134.760.00%
1 qtr
First report
0

JPMorgan Chase & Co

37.4M$3.8B1.6%$82.700.00%
1 qtr
First report
0

Canadian National Railway Co

35.5M$3.2B1.3%$77.510.00%
1 qtr
First report
0

Alphabet Inc

2.7M$3.2B1.3%$58.290.00%
1 qtr
First report
0

Amazon.com Inc

1.6M$2.9B1.2%$89.040.00%
1 qtr
First report
0

PPG Industries Inc

24.1M$2.7B1.1%$97.330.00%
1 qtr
First report
0

Danaher Corp

20.1M$2.7B1.1%$112.950.00%
1 qtr
First report
0

Abbott Laboratories

32.8M$2.6B1.1%$69.760.00%
1 qtr
First report
0

Texas Instruments Inc

24.5M$2.6B1.1%$86.170.00%
1 qtr
First report
0
14.4M$2.5B1.1%$159.240.00%
1 qtr
First report
0

Pfizer Inc

56.7M$2.4B1.0%$28.060.00%
1 qtr
First report
0

Colgate-Palmolive Co

33M$2.3B1.0%$57.390.00%
1 qtr
First report
0
$237.3B
AUM
832
Positions
Q1 2019
Filing
HI score · 2.5/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q1'19

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ manages $237.3B across 832 positions as of Q1 2019. Top holdings: ACN (2.4%), CMCSA (2.4%), MDT (2.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2.5/5.0.

Q1 2019 Summary

First quarter we have for this fund: 832 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $237.3B across 832 positions.

Top holdings by portfolio weight

Total AUM$237B
ACN2.44%
CMCSA2.37%
MDT2.19%
TMO2.05%
V1.93%
JNJ1.66%
MSFT1.64%
AON1.63%
HON1.62%
JPM1.60%
Other1.34%

Portfolio allocation by GICS sector

Sectors11
Financial Services19.35%
Technology15.92%
Healthcare15.40%
Industrials11.63%
Communication Services7.52%
Unknown6.53%
Consumer Cyclical5.74%
Consumer Defensive5.36%
Basic Materials3.78%
Utilities3.50%
Other5.26%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Financial Services, Technology, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L55
Conviction40
Concentration35
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
AXONAXONAxon Enterprise Inc
Q4 2024 → Q2 2026+717,876 shares+$453.5M
7Q
BTIBTIBRITISH AMERN TOB PLC
Q4 2024 → Q2 2026+643,933 shares+$43M
7Q
CRUSCRUSCIRRUS LOGIC INC COM
Q4 2024 → Q2 2026+101,103 shares+$15.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used